Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 3 Thrombocytopenia 2 Pathologic Complete Response 2 Multiple Myeloma 2 Uterine Cervical Neoplasms 1 Sarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Oligometastatic Disease 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Leukemia 1 Leiomyosarcoma 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 HER2 Negative Breast Cancer 1 Glioma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Tretinoin 1 Radiosurgery 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Oligometastatic Disease × Tretinoin × Clear all

NCT06439888 2025-12-01

LySATRA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Other solid neoplasm

Oligometastatic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡